MyFinsight
Home
Blog
About
Accounts receivable
$887,000K
(48.90%↑ Y/Y)
Cash and cash
equivalents
$332,400K
(25.91%↑ Y/Y)
Prepaid expenses
$217,100K
Inventory
$104,200K
(83.13%↑ Y/Y)
Available-for-sale debt securities
$57,400K
(-91.93%↓ Y/Y)
Other current assets
$39,400K
(-67.36%↓ Y/Y)
Intangible assets, net
$2,226,000K
(5883.87%↑ Y/Y)
Total current assets
$1,637,500K
(-6.37%↓ Y/Y)
Goodwill
$500,600K
Right-of-use assets
$448,000K
(-9.00%↓ Y/Y)
Noncurrent inventory
$149,100K
Equity investments
$147,300K
(68.34%↑ Y/Y)
Noncurrent
available-for-sale debt securities
$91,900K
(-89.48%↓ Y/Y)
Property and equipment,
net
$90,500K
(-1.31%↓ Y/Y)
Other noncurrent
assets
$59,300K
(174.54%↑ Y/Y)
Deferred tax assets
$8,900K
(-98.34%↓ Y/Y)
Total assets
$5,359,100K
(37.77%↑ Y/Y)
Total liabilities and
stockholders equity
$5,359,100K
(37.77%↑ Y/Y)
Total stockholders
equity
$3,693,600K
(37.09%↑ Y/Y)
Total liabilities
$1,665,500K
(39.31%↑ Y/Y)
Additional paid-in capital
$2,964,400K
(14.14%↑ Y/Y)
Retained earnings
$724,000K
(756.80%↑ Y/Y)
Accumulated other
comprehensive income
$5,100K
(-59.20%↓ Y/Y)
Total current
liabilities
$874,500K
(60.08%↑ Y/Y)
Noncurrent operating lease
liabilities
$401,800K
(-8.49%↓ Y/Y)
Other noncurrent
liabilities
$297,700K
(41.69%↑ Y/Y)
Deferred tax liabilities
$91,500K
Accounts payable and
accrued liabilities
$808,300K
(65.13%↑ Y/Y)
Other current
liabilities
$66,200K
(16.55%↑ Y/Y)
Back
Back
Balance Sheet
NEUROCRINE BIOSCIENCES INC (NBIX)
NEUROCRINE BIOSCIENCES INC (NBIX)
source: myfinsight.com